Concepedia

José Rodrigues-Pereira

JR

Statistics

Publications

4

Citations

764

H-Index

4

Active since

2003

Affiliations

Universidad Abierta Interamericana(Current)

José Rodrigues-Pereira is an author at Universidad Abierta Interamericana specializing in pharmacology, oncology, and medicine.

Publications per year

2003–2013

4

Publications

4

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

S. Poli-Bigelli, José Rodrigues-Pereira, Alexandra D. Carides et al. · Cancer · 2003 · 566 citations

Medicine, Oncology, Pharmacology +17

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes et al. · Journal of Thoracic Oncology · 2011 · 95 citations · Full text

Medicine, Oncology, Pharmacology +10

Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer

Jung Shin Lee, Sang‐We Kim, José Rodrigues-Pereira et al. · European Journal of Cancer · 2013 · 78 citations

Medicine, Oncology, Pharmacology +9

A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Jacek Jassem, Petr Zatloukal, Rodryg Ramlau et al. · Journal of Clinical Oncology · 2005 · 25 citations

Medicine, Oncology, Pharmacology +12

1–4 of 4